case_images: PMC10850233_01
case_images: Clinical course of patients with persistent COVID-19 infections. (A). Clinical course of a 76-year-old male with mantle cell lymphoma developing persistent COVID-19 infection. (B). Clinical course of a 78-year-old male with diffuse large B-cell lymphoma developing persistent COVID-19 infection. Ag, antigen; Ct, cycle threshold; E, envelope; ESV, Ensitrelvir; DEX, dexamethasone; G-CSF, granulocyte-colony stimulating factor; MOL, Molnupiravir; Neut, neutrophil; PC, platelet concentrate; Plt, Platelet; RDV, Remdesivir; SOT, Sotrovimab; TOC, Tocilizumab.
case_images: fimmu-15-1287300-g001.jpg
case_images: PMC10850233_02_fimmu-15-1287300-g001.jpg
case_images: f1
case_images: The patient desired no further treatment, and he was discharged to a nursing home ( Figure 1B ).
case_images: PMC10850233_02
case_images: Clinical course of patients with persistent COVID-19 infections. (A). Clinical course of a 76-year-old male with mantle cell lymphoma developing persistent COVID-19 infection. (B). Clinical course of a 78-year-old male with diffuse large B-cell lymphoma developing persistent COVID-19 infection. Ag, antigen; Ct, cycle threshold; E, envelope; ESV, Ensitrelvir; DEX, dexamethasone; G-CSF, granulocyte-colony stimulating factor; MOL, Molnupiravir; Neut, neutrophil; PC, platelet concentrate; Plt, Platelet; RDV, Remdesivir; SOT, Sotrovimab; TOC, Tocilizumab.
case_images: fimmu-15-1287300-g001.jpg
case_images: PMC10850233_02_fimmu-15-1287300-g001.jpg
case_images: f1
case_images: The patient desired no further treatment, and he was discharged to a nursing home ( Figure 1B ).